Stereotaxis (STXS) Total Non-Current Liabilities (2010 - 2026)
Stereotaxis' (STXS) quarterly Total Non-Current Liabilities came in at $29.3 million in Q1 2026, down 6.23% year-over-year from $31.3 million in Q1 2025, and up 1.8% quarter-over-quarter from $28.8 million in Q4 2025.
Analysis
Stereotaxis (STXS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Total Non-Current Liabilities for 17 consecutive years, with $29.3 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 6.23% year-over-year to $29.3 million in Q1 2026; TTM through Mar 2026 was $29.3 million, a 6.23% decrease from a year earlier, with the FY2025 full-year figure at $28.8 million, down 1.23% from the prior year.
- Total Non-Current Liabilities was $29.3 million for Q1 2026 at Stereotaxis, up from $28.8 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $31.3 million in Q1 2025 and troughed at $19.2 million in Q2 2024.
- A 5-year average of $24.0 million and a median of $21.4 million in 2022 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities fell 10.5% in 2023 and soared 61.37% in 2025, its largest moves.
- Over 5 years, Total Non-Current Liabilities stood at $21.4 million in 2022, then declined by 6.94% to $19.9 million in 2023, then jumped by 46.22% to $29.2 million in 2024, then dropped by 1.23% to $28.8 million in 2025, then climbed by 1.8% to $29.3 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $29.3 million (Q1 2026), $28.8 million (Q4 2025), and $27.0 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | 29.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 29.32 Mn |
| Dec 31, 2025 | 28.81 Mn |
| Sep 30, 2025 | 27.04 Mn |
| Jun 30, 2025 | 28.04 Mn |
| Mar 31, 2025 | 31.27 Mn |
| Dec 31, 2024 | 29.17 Mn |
| Sep 30, 2024 | 28.46 Mn |
| Jun 30, 2024 | 19.20 Mn |
| Mar 31, 2024 | 19.38 Mn |
| Dec 31, 2023 | 19.95 Mn |
| Sep 30, 2023 | 20.19 Mn |
| Jun 30, 2023 | 21.30 Mn |
| Mar 31, 2023 | 21.37 Mn |
| Dec 31, 2022 | 21.43 Mn |
| Sep 30, 2022 | 22.56 Mn |
| Jun 30, 2022 | 20.95 Mn |
| Mar 31, 2022 | 19.32 Mn |
| Dec 31, 2021 | 21.34 Mn |
| Sep 30, 2021 | 21.55 Mn |
| Jun 30, 2021 | 15.08 Mn |